Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1001/jamaophthalmol.2013.576 | DOI Listing |
J Vis
January 2025
McGill Vision Research, Department of Ophthalmology & Visual Sciences, McGill University, Montreal, QC, Canada.
Here, we investigate the shift in eye balance in response to monocular cueing in adults with amblyopia. In normally sighted adults, biasing attention toward one eye, by presenting a monocular visual stimulus to it, can shift eye balance toward the stimulated eye, as measured by binocular rivalry. We investigated whether we can modulate eye balance by directing monocular stimulation/attention in adults with clinical binocular deficits associated with amblyopia and larger eye imbalances.
View Article and Find Full Text PDFClin Ophthalmol
November 2024
Department of Ophthalmology, Stanford University School of Medicine, Stanford, CA, USA.
Cannabis is the most used drug worldwide with an estimated 219 million users. This narrative review aims to explore the adverse effects and therapeutic applications of cannabis and cannabinoids on the eye, given its growing clinical and non-clinical uses. The current literature reports several adverse ocular effects of cannabis and cannabinoids, including eyelid tremor, ptosis, reduced corneal endothelial cell density, dry eyes, red eyes, and neuro-retinal dysfunction.
View Article and Find Full Text PDFClin Ophthalmol
November 2024
Triangle Eye Consultants, Raleigh, NC, USA.
Purpose: To evaluate the efficacy of 0.2% and 0.4% pilocarpine HCl (CSF-1) for the treatment of presbyopia and to determine the contributions of pilocarpine HCl and diclofenac sodium on the efficacy of fixed-dose combination (FDC) formulations.
View Article and Find Full Text PDFOphthalmol Retina
November 2024
Department of Ophthalmology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
J Vasc Surg
November 2024
Department of Vascular and Endovascular Surgery, Mayo Clinic Health System, Eau Claire, WI. Electronic address:
Background: The long-term neuro-ophthalmic outcomes after carotid intervention in patients presenting with preoperative visual symptoms vary widely based on the underlying etiology of retinal ischemia and are not well understood.
Methods: We performed a retrospective review of consecutive patients presenting with retinal ischemia who subsequently underwent carotid intervention from January 2018 to December 2022. Patients were classified into three groups (group I: amaurosis fugax/vascular transient monocular vision loss, group II: ocular ischemic syndrome [OIS], and group III: central/branch retinal artery occlusion).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!